Over the next decade, the life sciences industries will be faced with sweeping demographic shifts, increasing globalization, mounting health care costs, the rise of emerging markets, and accelerating convergence between industry sectors. The life sciences industries are clearly poised for a period of massive shifts, and the most successful players in 2015 will be those whose strategies not only reflect these trends, but also adapt to and take advantage of them. To do so, life sciences companies must first clearly understand the forces that are changing the industries, and the issues that they will need to overcome in order to be successful in 2015. To help understand how companies are aligning themselves for success, Deloitte Touche Tohmatsu, in collaboration with the Economist Intelligence Unit, has completed a research programme that culminates in the following white paper, entitled “The Future of the Life Sciences Industries: Strategies for Success in 2015.” As the research makes clear, positioning for success will require many companies to challenge their strategies regarding business models, markets, products, alliances and other areas. And in some cases, broad transformation of critical aspects of the business may be needed. Publisher trust that this document will provide compelling insight into those issues and strategies that will dominate the corporate agenda for the next decade – and beyond.
regulanet®: Local representation for Global Regulatory Affairs

Tarius - Regulatory Intelligence Databases
Pharmaceutical Licensing and technology transfer
